AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Suglow G 3mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

BRD MediLabs

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Suglow G 3mg/500mg Tablet

Diabexe Duo 3mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continued use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are pivotal in diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal dysfunction. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.

Primary Ingredients of Suglow G 3mg/500mg Tablet

There is no text provided to rephrase.

Uses of Suglow G 3mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Suglow G 3mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the Suglow G 3mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Suglow G 3mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Suglow G 3mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Suglow G 3mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Suglow G 3mg/500mg Tablet works:

Suglow G, a 3mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Suglow G 3mg/500mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Suglow G 3mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not use Suglow G 3mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Suglow G 3mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates use of Suglow G 3mg/500mg tablets. Consult a physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Suglow G 3mg/500mg tablets. Dosage modifications may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, a low initial dose of Suglow G 3mg/500mg tablets is typically recommended; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Suglow G 3mg/500mg Tablet :

Should you forget a Suglow G 3mg/500mg Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Suglow G 3mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Suglow G 3mg/500mg Tablet

Maintain this medication within its original, sealed container. Follow the storage directions provided on the packaging. Discard any remaining medicine. Ensure it remains inaccessible to children, animals, and unauthorized individuals.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential adverse effect of Suglow G 3mg/500mg Tablet. Also termed Metformin-associated lactic acidosis (MALA), this rare complication poses a significant risk to individuals with compromised kidney function, the elderly, and heavy alcohol consumers. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. Should any of these symptoms occur, discontinue Suglow G 3mg/500mg Tablet use and seek immediate medical attention.
Suglow G 3mg/500mg tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances glycemic control when combined with a healthy diet and exercise regimen. Glimepiride stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose production and boosts insulin sensitivity. This formulation is unsuitable for type 1 diabetes.
Suglow G 3mg/500mg Tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged administration might result in vitamin B12 deficiency.
Prolonged use of Suglow G 3mg/500mg Tablets can indeed lead to Vitamin B12 deficiency. This medication hinders the stomach's absorption of Vitamin B12. Consequently, untreated deficiency may result in anemia, neurological issues such as tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and balance difficulties (ataxia). To mitigate these risks, supplemental Vitamin B12 is recommended by some studies at least annually.
Indeed, taking Suglow G 3mg/500mg tablets may lead to hypoglycemia (low blood glucose). Low blood sugar can manifest as nausea, headache, restlessness, hunger pangs, sweating, lightheadedness, a rapid pulse, and feelings of unease or trembling. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concurrent use of other diabetes medications. Consequently, consistent blood glucose monitoring is crucial. Always carry a readily available fast-acting sugar source such as glucose tablets, honey, or fruit juice.
Combining Suglow G 3mg/500mg Tablet and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Suglow G 3mg/500mg Tablet
70
MRP 85
17% off